TrialCancer chemotherapy and pharmacology2022

A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan.

Kenichi Ishizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.